Methodologic considerations in treatment using intraperitoneal chemotherapy.
Averbach
A M
AM
Washington Cancer Institute, DC 20010, USA.
Sugarbaker
P H
PH
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D016503:Drug Delivery Systems; D005260:Female; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy; D010529:Peritoneal Cavity; D010534:Peritoneal Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents